Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2388]

STING activation reduces graft-versus-host disease in a mouse model

STING activation reduces graft-versus-host disease in a mouse model

Study: New prostate cancer test could avoid unnecessary biopsies

Study: New prostate cancer test could avoid unnecessary biopsies

New data from the phase 3 CLEAR trial demonstrate significant improvement in progression free survival and overall survival versus standard of care in advanced renal cell carcinoma

New data from the phase 3 CLEAR trial demonstrate significant improvement in progression free survival and overall...

Researchers, healthcare providers, voluntary organisations and parents warn community "not to lose momentum" in global fight against childhood cancer

Researchers, healthcare providers, voluntary organisations and parents warn community "not to lose momentum" in...

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Chemotherapy and hearing loss: Until now, an unquantified risk

Chemotherapy and hearing loss: Until now, an unquantified risk

Green tea compound aids tumour-suppressing, DNA-repairing protein

Green tea compound aids tumour-suppressing, DNA-repairing protein

WCLC 2020: Asian-relevant lung cancer research presented at Global Lung Cancer Conference hosted in Singapore

WCLC 2020: Asian-relevant lung cancer research presented at Global Lung Cancer Conference hosted in Singapore

More than half of cancer survivors have underlying medical conditions associated with severe COVID

More than half of cancer survivors have underlying medical conditions associated with severe COVID

FDA approves cemiplimab-rwlc for locally advanced and metastatic basal cell carcinoma

FDA approves cemiplimab-rwlc for locally advanced and metastatic basal cell carcinoma

More from ecancer